血红蛋白中的超快速CO动力学:阿迪亚巴特结合和重原子道化
Abdelkrim Benabbas1, Yuhan Sun1, Thomas L Poulos2
1Department of Physics and Center for Interdisciplinary Research on Complex Systems, Northeastern University , Boston, Massachusetts 02115, United States.
Journal of the American Chemical Society
|October 7, 2017
概括
碳一氧化物 (CO) 对ChCooA的重新结合是由于热因而形成的,与肌球蛋白和血红蛋白不同. 这项CO结合动力学研究揭示了低温时的血红蛋白动力学和量子道效应.
科学领域:
- 生物化学
- 物理化学
- 蛋白质动力学
背景情况:
- 一氧化碳激活蛋白 (ChCooA) 是一种参与CO代谢的血红蛋白.
- 了解连接蛋白与血红蛋白 (Myoglobin) 和血红蛋白 (Hb) 结合的动力学对于阐明它们的功能至关重要.
- 之前的研究通常假定CO与血红蛋白的结合是由于旋转选择规则而非adiabatic的.
研究的目的:
- 在广泛的温度范围内研究CO与ChCooA的超快速动力学.
- 将ChCooA中的CO再结合动力与Mb和Hb中的动力进行比较.
- 阐明控制二氧化碳结合机制的因素,包括附加性和性贡献.
主要方法:
- 超快速的运动测量CO重结成ChCooA.
- 从低温到室温的温度依赖的动力学研究.
- 实验数据与理论模型的比较,包括屏障分布和量子力学道.
主要成果:
- 对CO与ChCooA结合的阿雷尼乌斯前因子明显高 (∼10^11 s^-1) 比对Mb和Hb (∼10^9 s^-1),表明是一种基结合过程.
- 在所有温度下,CO与ChCooA的重新结合是无指数的,这归因于由血主导异质性引起的阻的分布.
- 温度依赖的动力学揭示了溶剂玻璃过渡 (Tg ≈ 180 K) 上方和下方的屏障分布的变化,而60 K以下的量子道变得显著.
结论:
- CO与ChCooA的结合是一种亚底离子过程,其中因子占主导地位.
- 血红异质性会产生重新结合障碍的分布,影响非指数动力学.
- 量子力学道在低温,特别是低于60K的温度下起作用.
相关概念视频
Protein-Drug Binding: Mechanism and Kinetics
1.9K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
1.9K
Cooperative Allosteric Transitions
9.0K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
9.0K
Cooperative Allosteric Transitions
3.2K
3.2K
Cooperative Allosteric Transitions
2.7K
2.7K
Enzyme Kinetics
104.6K
Enzymes speed up reactions by lowering the activation energy of the reactants. The speed at which the enzyme turns reactants into products is called the rate of reaction. Several factors impact the rate of reaction, including the number of available reactants. Enzyme kinetics is the study of how an enzyme changes the rate of a reaction.
Scientists typically study enzyme kinetics with a fixed amount of enzyme in the controlled environment of a test tube. When more reactant, or substrate, is...
Scientists typically study enzyme kinetics with a fixed amount of enzyme in the controlled environment of a test tube. When more reactant, or substrate, is...
104.6K
Ligand Binding and Linkage
5.7K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.7K


